Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review)

  • Authors:
    • Alessandro Allegra
    • Andrea Alonci
    • Salvatore Campo
    • Giuseppa Penna
    • Annamaria Petrungaro
    • Demetrio Gerace
    • Caterina Musolino
  • View Affiliations

  • Published online on: October 1, 2012     https://doi.org/10.3892/ijo.2012.1647
  • Pages: 1897-1912
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

MicroRNAs (miRNAs) are small non-coding, endogenous, single-stranded RNAs. MiRNAs have been implicated in different areas such as the immune response, neural development, DNA repair, apoptosis, oxidative stress response and cancer. However, while the majority of miRNAs are found intracellularly, a significant number of miRNAs have been observed outside of cells, including various body fluids. Circulating miRNAs function as ‘extracellular communication RNAs’ that play an important role in cell proliferation and differentiation. MiRNA regulation is essential to many cellular processes, and escape from this regulatory network seems to be a common characteristic of several disease processes and malignant transformation. The interest in circulating miRNAs reflects in fact their central role in regulation of gene expression and the implication of miRNA-specific aberrant expression in the pathogenesis of cancer, cardiac, metabolic, neurologic, immune-related diseases as well as others. In our review we aimed to summarize the data related to the action of cellular miRNAs on the onset of various diseases, thus bringing together some of the latest information available on the role of circulating miRNAs. Additionally, the role of circulating miRNAs could be particularly relevant in the context of neoplastic diseases. At least 79 miRNAs have been reported as plasma or serum miRNA biomarkers of solid and hematologic tumors. Circulating miRNA profiling could improve the diagnosis of cancer, and could predict outcome for cancer patients, while the profiling of alterations in circulating miRNA that may signal a predisposition to cancer, could also be a therapeutic target in these patients.
View References

Related Articles

Journal Cover

December 2012
Volume 41 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Allegra A, Alonci A, Campo S, Penna G, Petrungaro A, Gerace D and Musolino C: Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review). Int J Oncol 41: 1897-1912, 2012.
APA
Allegra, A., Alonci, A., Campo, S., Penna, G., Petrungaro, A., Gerace, D., & Musolino, C. (2012). Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review). International Journal of Oncology, 41, 1897-1912. https://doi.org/10.3892/ijo.2012.1647
MLA
Allegra, A., Alonci, A., Campo, S., Penna, G., Petrungaro, A., Gerace, D., Musolino, C."Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review)". International Journal of Oncology 41.6 (2012): 1897-1912.
Chicago
Allegra, A., Alonci, A., Campo, S., Penna, G., Petrungaro, A., Gerace, D., Musolino, C."Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review)". International Journal of Oncology 41, no. 6 (2012): 1897-1912. https://doi.org/10.3892/ijo.2012.1647